120 related articles for article (PubMed ID: 6902677)
1. Toxicity of anticancer drugs used in children.
Reich SD
Cancer Nurs; 1980 Oct; 3(5):385-6. PubMed ID: 6902677
[No Abstract] [Full Text] [Related]
2. Serious toxicities associated with chemotherapy.
Friedman MA; Carter SB
Semin Oncol; 1978 Jun; 5(2):193-202. PubMed ID: 79220
[No Abstract] [Full Text] [Related]
3. [Cerebral ischemic events and anti-cancer therapy].
El Amrani M; Aidi S; Amarenco P
Rev Neurol (Paris); 2003 Apr; 159(4):371-80. PubMed ID: 12773866
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic anemia associated with antineoplastic agents.
Doll DC; Weiss RB
Cancer Treat Rep; 1985; 69(7-8):777-82. PubMed ID: 3160460
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to cancer chemotherapeutic agents.
Weiss RB; Bruno S
Ann Intern Med; 1981 Jan; 94(1):66-72. PubMed ID: 7004302
[TBL] [Abstract][Full Text] [Related]
6. [Neurological problems in malignant hemopathies in children. II. Neurotoxicity of antiblastic drugs and radiotherapy].
Galletti F; Sturniolo MG
Minerva Pediatr; 1982 Jun; 34(11):485-91. PubMed ID: 6752689
[No Abstract] [Full Text] [Related]
7. [Neurotoxicity of some antineoplastic agents].
Mitolo-chieppa D; Ceci A
Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1333-59. PubMed ID: 4458721
[No Abstract] [Full Text] [Related]
8. Hypersensitivity reactions.
Weiss RB
Semin Oncol; 1992 Oct; 19(5):458-77. PubMed ID: 1384149
[TBL] [Abstract][Full Text] [Related]
9. [Protective effect of metallothionein against toxicity of anticancer drugs].
Naganuma A; Imura N
Tanpakushitsu Kakusan Koso; 1987 Jul; 32(8):1031-40. PubMed ID: 3313521
[No Abstract] [Full Text] [Related]
10. [Toxic myocardiopathies in pediatrics (author's transl)].
Fermont L; Zucker JM; Maynier M; Asselain B
Ann Pediatr (Paris); 1981 Mar; 28(5):355-8. PubMed ID: 7247228
[No Abstract] [Full Text] [Related]
11. [Doxorubicin and cisplatin genotoxicity: search for a real indication using the micronucleus test].
Duffaud F; Orsière T; Baciuchka-Palmaro M; Digue L; Favre R; Botta A
Ann Biol Clin (Paris); 1998; 56(2):183-7. PubMed ID: 9754244
[TBL] [Abstract][Full Text] [Related]
12. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
Hofland KF; Thougaard AV; Sehested M; Jensen PB
Clin Cancer Res; 2005 May; 11(10):3915-24. PubMed ID: 15897593
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics].
Sawada T; Matsumura T; Mugishima H; Kaneko M; Ohira M; Sugimoto T; Onuma N; Sakurai M; Takeda T
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1295-304. PubMed ID: 10478183
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
15. [Cytostatic therapy: neurologic and psychiatric syndromes].
Strian F; Maurach R
Med Klin; 1980 Jun; 75(13):478-84. PubMed ID: 6997713
[No Abstract] [Full Text] [Related]
16. Cancer chemotherapy: those dreaded side effects and what to do about them. Part five.
Levitt DZ
RN; 1981 Feb; 44(2):56-9. PubMed ID: 6906871
[No Abstract] [Full Text] [Related]
17. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
18. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
20. Renal complications of cytotoxic therapy.
Healy HG; Clarkson AR
Aust N Z J Med; 1983 Oct; 13(5):531-9. PubMed ID: 6228218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
